ClinicalTrials.gg
Sign In

Leiomyoma clinical trials

The registry lists 438 studies for Leiomyoma across more than 10 countries. 74 are recruiting or about to start. 354 of them are mainly about Leiomyoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Leiomyoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
210
Status unknown
60
Terminated
53
Recruiting
43
Not yet recruiting
27
Active, not recruiting
21

Phase

Phase 3
71
Phase 2
48
Phase 4
42
Phase 1
23
Early Phase 1
6

Where

United States
156
China
39
Italy
30
Canada
25
United Kingdom
24
France
22

Who runs them

Repros Therapeutics Inc. (18) · Bayer (12) · InSightec (10) · Abbott (9) · AbbVie (8) · Gynesonics (7) · University Magna Graecia (7) · Philips Healthcare (6)

What is being tested here

Drugs under test in Leiomyoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Relugolix2910
Vitamin D202
Tranexamic Acid115
Bupivacaine114
Epigallocatechin gallate103
Letrozole103
Terlipressin101
Cyclobenzaprine101
Proteasomal Ubiquitin Receptor ADRM1101
Dextromethorphan101

Drug classes tested here Local anesthetics 1 open · Hormonal contraceptives 21 · NSAIDs 3

Coming up

7phase 3 studies under way
26studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 43 Leiomyoma studies recruiting now, 21 (49%) set no upper age limit and 21 (49%) stop at 75 or younger. 3 (7%) take children under 18. 40 (93%) are for women only and 0 (0%) for men only; 9 (21%) take healthy volunteers.

Recruiting studies that take each age, of 43
AgeWomenMen
103 (7%)1 (2%)
1838 (88%)3 (7%)
3043 (100%)3 (7%)
4043 (100%)3 (7%)
5036 (84%)3 (7%)
6524 (56%)3 (7%)
7523 (53%)3 (7%)
8522 (51%)3 (7%)

Across all 438 studies, recruiting or not: 58% stop at 75 or younger and 56% at 65; 8% take children; 95% are for women only and <1% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leiomyoma studies take

Of 25 phase 3 interventional studies under Leiomyoma, half reached primary completion within 27 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 114 mo3–41 · 13 studies——
Phase 327 mo23–41 · 25 studies——
Interventional, no phase31 mo15–43 · 57 studies—32 mo14–43 · 52 studies
Observational29 mo16–99 · 45 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 438. Browse all 438 → or search them.